NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: Levi & Korsinsky
Notice to Pension Funds, Asset Managers, and Fiduciaries NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) — Institutional investors holding positions…
